Similar articles for PMID: 27347348

Year	Number of Results
2011	1
2012	1
2014	4
2015	23
2016	23
2017	21
2018	17
2019	14
2020	6
2021	4
2022	1
2023	2
2024	0

1

The role and expression of miR-100 and miR-203 profile as prognostic markers in epithelial ovarian cancer.

Azizmohammadi S, Azizmohammadi S, Safari A, Kosari N, Kaghazian M, Yahaghi E, Seifoleslami M. Azizmohammadi S, et al. Am J Transl Res. 2016 May 15;8(5):2403-10. eCollection 2016. Am J Transl Res. 2016. PMID: 27347348 Free PMC article.

2

Down-regulated miR-22 as predictive biomarkers for prognosis of epithelial ovarian cancer.

Wan WN, Zhang YQ, Wang XM, Liu YJ, Zhang YX, Que YH, Zhao WJ, Li P. Wan WN, et al. Diagn Pathol. 2014 Sep 26;9:178. doi: 10.1186/s13000-014-0178-8. Diagn Pathol. 2014. PMID: 25257702 Free PMC article.

3

The down-regulation of long non-coding RNA LINC01088 is associated with the poor prognosis of epithelial ovarian cancer patients.

Ai H, Xie W, Xiu AH, Li N, Zhang ST, Zhang YL, Xue XO. Ai H, et al. Eur Rev Med Pharmacol Sci. 2018 Sep;22(18):5836-5841. doi: 10.26355/eurrev_201809_15910. Eur Rev Med Pharmacol Sci. 2018. PMID: 30280763 Free article.

4

miR-532-5p is a prognostic marker and suppresses cells proliferation and invasion by targeting TWIST1 in epithelial ovarian cancer.

Wei H, Tang QL, Zhang K, Sun JJ, Ding RF. Wei H, et al. Eur Rev Med Pharmacol Sci. 2018 Sep;22(18):5842-5850. doi: 10.26355/eurrev_201809_15911. Eur Rev Med Pharmacol Sci. 2018. PMID: 30280764 Free article.

5

MicroRNA-184 acts as a potential diagnostic and prognostic marker in epithelial ovarian cancer and regulates cell proliferation, apoptosis and inflammation.

Qin CZ, Lou XY, Lv QL, Cheng L, Wu NY, Hu L, Zhou HH. Qin CZ, et al. Pharmazie. 2015 Oct;70(10):668-73. Pharmazie. 2015. PMID: 26601424

6

Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections.

Marchini S, Cavalieri D, Fruscio R, Calura E, Garavaglia D, Fuso Nerini I, Mangioni C, Cattoretti G, Clivio L, Beltrame L, Katsaros D, Scarampi L, Menato G, Perego P, Chiorino G, Buda A, Romualdi C, D'Incalci M. Marchini S, et al. Lancet Oncol. 2011 Mar;12(3):273-85. doi: 10.1016/S1470-2045(11)70012-2. Epub 2011 Feb 21. Lancet Oncol. 2011. PMID: 21345725

7

Down-regulation of miR-133a and miR-539 are associated with unfavorable prognosis in patients suffering from osteosarcoma.

Mirghasemi A, Taheriazam A, Karbasy SH, Torkaman A, Shakeri M, Yahaghi E, Mokarizadeh A. Mirghasemi A, et al. Cancer Cell Int. 2015 Sep 17;15:86. doi: 10.1186/s12935-015-0237-6. eCollection 2015. Cancer Cell Int. 2015. PMID: 26388701 Free PMC article. Retracted.

8

Mir-595 is a significant indicator of poor patient prognosis in epithelial ovarian cancer.

Zhou QH, Zhao YM, Jia LL, Zhang Y. Zhou QH, et al. Eur Rev Med Pharmacol Sci. 2017 Oct;21(19):4278-4282. Eur Rev Med Pharmacol Sci. 2017. PMID: 29077170 Free article.

9

Title Prognosis Significance of ZEB2 and TGF-β1 as well as Other Clinical Characteristics in Epithelial Ovarian Cancer.

Yan Z, Tian X, Wang R, Cheng X, Mi J, Xiong L, Wang Y, Deng J, Jia M. Yan Z, et al. Int J Gynecol Cancer. 2017 Sep;27(7):1343-1349. doi: 10.1097/IGC.0000000000001037. Int J Gynecol Cancer. 2017. PMID: 30814239

10

Overexpression of lncRNA MNX1-AS1 is associated with poor clinical outcome in epithelial ovarian cancer.

Li AH, Zhang HH. Li AH, et al. Eur Rev Med Pharmacol Sci. 2017 Dec;21(24):5618-5623. doi: 10.26355/eurrev_201712_14003. Eur Rev Med Pharmacol Sci. 2017. PMID: 29271994 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

108 results

Results by year